New updates to the ICMJE’s reporting recommendations: focus on transparency
We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
Can you trust an article’s abstract?
Abstract ‘spin’ can distort a study’s findings and lead to inappropriate conclusions being drawn. But just how prevalent is this problem?
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
MPIP: Overcoming barriers to open access for industry
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
Are European universities failing to report clinical trial data in a timely manner?
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
CBI’s 8th Annual Publication and Clinical Trial Transparency Europe
Join CBI for the latest updates on data sharing, collaborating with patients and innovations in publishing.
Five essential factors for data sharing
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
Are ‘funding body journals’ the future of scientific publishing?
A recent article from The Chronicle of Higher Education discusses the potential benefits associated with journals that are established by funding bodies.
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
It’s time to increase awareness of data ‘FAIRness’
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
Self-citation by peer reviewers: when is it appropriate and how to safeguard against malpractice
Authors and editors are asked to be vigilant, and advice to peer reviewers is updated, amidst scandal of reviewer who asked for multiple self-citations during reviews.
Can holding institution heads to account lead to improved rates of clinical trial reporting?
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Consolidation and regulation is driving the current state of scholarly communications
A recent blog for The Scholarly Kitchen suggests mergers, acquisitions, and new regulations are increasingly changing the state of scholarly communications.
Open peer review: pilot studies reveal promising findings
As an increasing number of journals pilot transparent peer review, data indicate that open peer review does not compromise the process – at least when reviewers can stay anonymous.